Antibacterial Drugs That Interfere With DNA/RNA Synthesis

Antibacterial Drugs That Interfere With DNA/RNA Synthesis
paly

This presentation is an introduction to clinical pharmacology chapter 9 on Antibacterial Drugs That Interfere With DNA/RNA Synthesis. The focus is on flu

  • Uploaded on | 2 Views
  • polyan polyan

About Antibacterial Drugs That Interfere With DNA/RNA Synthesis

PowerPoint presentation about 'Antibacterial Drugs That Interfere With DNA/RNA Synthesis'. This presentation describes the topic on This presentation is an introduction to clinical pharmacology chapter 9 on Antibacterial Drugs That Interfere With DNA/RNA Synthesis. The focus is on flu. The key topics included in this slideshow are . Download this presentation absolutely free.

Presentation Transcript


Slide1Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis Introduction to Clinical Pharmacology Chapter 9 Antibacterial Drugs That Interfere With DNA/RNA Synthesis

Slide2Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Fluoroquinolones Fluoroquinolones • Ciprofloxacin (Cipro) • Gemifloxacin (Factive) • Levofloxacin (Levaquin) • Moxifloxacin (Avelox) • Norfloxacin (Noroxin)

Slide3Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Fluoroquinolones: Actions Fluoroquinolones: Actions • Bactericidal effect: – Interfere with the synthesis of bacterial DNA • Prevents cell reproduction, leading to death of the bacteria

Slide4Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Fluoroquinolones: Uses Fluoroquinolones: Uses • Used to treat infections caused by gram- positive and gram-negative microorganisms • Used for the treatment of: – Lower respiratory infections – Bone and joint infections – Urinary tract infections and infections of the skin – Sexually transmitted diseases

Slide5Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Fluoroquinolones: Adverse Reactions Fluoroquinolones: Adverse Reactions • Common adverse effects: – Nausea; diarrhea; headache; abdominal pain or discomfort; dizziness • Serious adverse effects: – Photosensitivity and hypersensitivity – Bacterial or fungal superinfections – Pseudomembranous colitis

Slide6Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Fluoroquinolones: Contraindications and Precautions Fluoroquinolones: Contraindications and Precautions • Contraindicated: – In patients with a history of hypersensitivity; in children younger than 18 years; during pregnancy; in patients who cannot follow precautions regarding photosensitivity • Used cautiously in: – Patients with renal impairment; patients with history of seizures; geriatric patients ;  patients  on dialysis

Slide7Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Fluoroquinolones: Interactions Fluoroquinolones: Interactions Interactant drug Effect of interaction Theophylline Increased serum level Cimetidine (Tagamet) Hampers elimination of antibiotic Oral anticoagulants Increased risk of bleeding Antacids, iron salts, or zinc Decreased antibiotic absorption NSAIDs Risk of seizure

Slide8Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Question Question • Is the following statement true or false? • Fluoroquinolones are the primary class of bactericidal drugs affecting the bacterial cell by interfering with the synthesis of RNA.

Slide9Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Answer Answer • False • Fluoroquinolones are the primary class of bactericidal drugs affecting the bacterial cell by interfering with the synthesis of DNA. These drugs are used to treat a wide range of both gram-negative and gram-positive microorganisms.

Slide10Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Assessment Nursing Process: Assessment • Preadministration assessment: – Take and record vital signs and identify symptoms and history of drug allergies – Primary health care provider may order: • Culture and sensitivity: To be done before first dose of the drug is given • Renal and hepatic function tests; CBC; urinalysis

Slide11Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Assessment (cont.) Nursing Process: Assessment (cont.) • Ongoing assessment: – Monitor patient’s vital signs and for any adverse reactions during the first 48 hours • Notify the primary health care provider of any adverse reaction before the next dose of the drug is due

Slide12Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Nursing Diagnosis Nursing Process: Nursing Diagnosis • Risk for Impaired Comfort  related to fever • Risk for Impaired Skin Integrity  related to photosensitivity • Acute Pain  related to tissue injury during drug therapy • Diarrhea  related to superinfection secondary to antibiotic therapy adverse drug reaction  

Slide13Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Planning Nursing Process: Planning • The expected outcome includes an optimal response to therapy based on the reason for administration of the anti-infective: – Management of adverse drug reactions – Decrease in anxiety – Understanding of and compliance with the prescribed treatment regimen

Slide14Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation Nursing Process: Implementation • Promoting an optimal response therapy: – Observe patients for adverse reactions: Notify primary health care provider – Intramuscular administration: Monitor, record, and develop a plan for rotating injection sites – Intravenous administration: Monitor needle site; check rate of infusion; inspect the vein

Slide15Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation (cont.) Nursing Process: Implementation (cont.) • Monitoring and managing patient needs: – Diarrhea • Check and record the color and consistency of each stool – Acute pain at injection site • Inform the patient about discomfort • Use proper flush solution

Slide16Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Question Question • Is the following statement true or false? • Frequent liquid stools may be an indication of a superinfection or pseudomembranous colitis.

Slide17Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Answer Answer • True • Frequent liquid stools may be an indication of a superinfection or pseudomembranous colitis. If pseudomembranous colitis occurs, it is usually seen 4 to 10 days after treatment is started.

Slide18Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation Nursing Process: Implementation • Educating the patient and family: – Explain the importance of taking the drug at prescribed time intervals and as directed – Advise about the importance of completing the entire course of treatment – Explain the necessity of contacting the primary health care provider immediately if symptoms occur

Slide19Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation (cont.) Nursing Process: Implementation (cont.) • Monitoring and managing patient needs: – Acute pain: Tissue injury • Inspect needle site, rate of infusion, and vein for signs of tenderness, pain, and redness

Slide20Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation (cont.) Nursing Process: Implementation (cont.) • Monitoring and managing patient needs (cont.): – Diarrhea • Check the patient’s stools and report any incidence of diarrhea or the presence of blood and mucus immediately

Slide21Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation (cont.) Nursing Process: Implementation (cont.) • Educating the patient and family: – Explain the adverse reactions of specific prescribed antibiotic – Advise about the signs and symptoms of potentially serious adverse effects

Slide22Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation (cont.) Nursing Process: Implementation (cont.) • Educating the patient and family (cont.): – Explain the necessity of contacting the primary health care provider immediately if symptoms occur – Develop a teaching plan to include the information that appears in the Home Care Checklist

Slide23Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Evaluation Nursing Process: Evaluation • The therapeutic effect is achieved; infection is controlled; bowel is cleansed sufficiently if surgery is to occur • Fluid intake and output is appropriate

Slide24Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Evaluation (cont.) Nursing Process: Evaluation (cont.) • Adverse reactions are identified, reported, and managed • Patient and family demonstrate understanding of the drug regimen • Patient verbalizes the importance of complying with the prescribed therapeutic regimen

Slide25Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Question Question • Is the following statement true or false? • When medications are given IV, the vein needs to be monitored frequently because the medications can be irritating to the tissue.

Slide26Copyright © 2014  Wolters Kluwer Health | Lippincott Williams & Wilkins Answer Answer • True • When medications are given IV, the vein needs to be monitored frequently because the medications can be irritating to the tissue.